Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

New Asta development candidate represents new type of PDE4 inhibitor

Sep. 15, 1998

Early clinical trial results reported for cilansetron at recent congress

Sep. 14, 1998

Nateglinide preclinical and clinical data featured at diabetes meeting

Sep. 14, 1998

Role of oral porcine spasmolytic polypeptide in GI disorders studied by Danish group

Sep. 14, 1998

Japanese researchers report progress in the gene therapy of gastric cancer

Sep. 14, 1998

Antisense oligodeoxynucleotide to rat ICAM-1 tested in rat model of enterocolitis

Sep. 14, 1998

Two new LTD4 antagonists from Pfizer with promising profiles

Sep. 11, 1998

Selective PDE4 inhibitors discovered at Jouveinal presented at ACS meeting

Sep. 11, 1998

New anxiolytic PBI derivative discovered at R.W. Johnson

Sep. 11, 1998

Novel binary compounds with agonist-antagonist effects in vivo

Sep. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...